Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for emergence quality in children after tonsillectomy under sevoflurane anesthesia
ChiCTR2500105976Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None and postoperative delirium (POD) (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Agitation in children during emergence from general anesthesia. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500105976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105976.